Diprivan Injection, Emulsion
Product Images NDC 63323-269

This is a product label for a sterile, nonpyrogenic solution containing EDTA to inhibit microbial growth. The solution should be discarded within 12 hours of opening. The recommended dosage can be found in the package insert. It should be stored between 4 to 25 degrees Celsius and should not be frozen. The solution is for intravenous administration. The label includes contact information for Novaplus and specifies that the vial should be shaken well before use. The product is a 10 mL single-dose vial made in Austria.*

This text provides information about an intravenous medication called DIPRIVAN, which comes in single-dose vials. It contains propofol as the active component along with soybean oil, glycerol, egg lecithin, and disodium edetate anhydrous. The medication should be used within 12 hours of opening and should be discarded after that. It emphasizes the importance of proper administration by trained individuals and continuous patient monitoring. The medication must be stored between 4°C to 25°C. The trademark DIPRIVAN is owned by Fresenius Kabi USA, LLC.*

The text refers to a sterile and nonpyrogenic medical product, "DIPRIVAN" (propofol) for intravenous administration. Each vial contains 200 mg of propofol in 20 mL solution (10 mg per mL). The product must be stored between 4° to 25°C (40° to 77°F) and should not be frozen. It contains EDTA to inhibit microbial growth and should be discarded within 12 hours of opening. Strict aseptic technique is recommended for use. Manufacturer details include Fresenius Kabi in Lake Zurich, IL, with the product made in Sweden. For dosage information, refer to the package insert and it is only for prescription use. The product label also indicates that the vial should be shaken well before use.*

This text is the label information for a medication intended for intravenous administration. It contains 1000 mg per 100 mL (10 mg per mL) and is to be used as a single-dose vial. The medication needs to be shaken well before use and should be discarded within 12 hours of opening. The formula includes soybean oil, lecithin, egg yolk phospholipids, and EDTA as active components. It should be stored between 4° and 25°C. The product is identified as Rxonly novaplus™.*

This text appears to be a description of a product for intravenous administration, specifically mentioning a 100mL vial that is to be used as a single-dose vial. It suggests shaking the product well before use and mentions the brand name "novaplus™."*